The majority of peer-reviewed research finds that gender-affirming care is associated with lower rates of suicidal thoughts, and in some studies, fewer suicide attempts. A Cornell University review of the available literature found a “robust international consensus” that gender transition, including hormones and surgeries, improves overall well-being, with reductions in anxiety, depression, and suicidality among the positive outcomes. But the picture is more nuanced than a simple yes or no, and the strength of evidence varies depending on the type of care and the outcome measured.
What the Research Shows for Hormones and Puberty Blockers
The strongest and most consistent findings involve hormone therapy and puberty blockers. A University of Washington analysis found that transgender youth who received gender-affirming hormones or puberty blockers had 60% lower odds of depression and 73% lower odds of self-harm or suicidal thoughts compared to those who did not receive these treatments.
A study published in the Journal of Adolescent Health looked specifically at transgender and nonbinary youth and found that those receiving hormone therapy had 26% lower odds of seriously considering suicide compared to peers who wanted the treatment but hadn’t received it. For youth under 18, the results were even more pronounced: hormone therapy was associated with 38% lower odds of a past-year suicide attempt.
For puberty blockers specifically, a study of over 20,000 transgender adults published in Pediatrics found that those who had received puberty suppression during adolescence had roughly 70% lower odds of lifetime suicidal ideation compared to those who wanted the treatment but never got it. That’s a substantial difference, though the researchers noted they did not detect a statistically significant difference in actual suicide attempts or attempts resulting in hospitalization.
That distinction matters. Suicidal ideation (thinking about suicide) and suicide attempts are related but separate outcomes, and the evidence is more consistent for reductions in ideation than in attempts.
What Happens Before and After Treatment
Some research tracks the same individuals over time rather than comparing separate groups. One study of 288 transgender adults found that 73.3% reported a history of suicidal ideation before starting gender-affirming treatment. After treatment, that number dropped to 43.4%. Suicide attempts showed an even sharper decline: 35.8% reported a prior attempt before treatment, compared to 9.4% after. In adjusted analyses, the odds of suicidal ideation were nearly four times higher before treatment than after, and the odds of a suicide attempt were more than five times higher before treatment.
Research from Manitoba, Canada, highlights what happens during the gap between deciding to transition and actually receiving care. Waitlist times for adolescents to get an initial assessment can stretch to two years. Clinicians and researchers have noted that suicide risk appears highest among people who have decided to medically transition but haven’t yet begun, and that risk drops significantly once transition is underway. Youth and caregivers interviewed during wait periods described spiraling mental health, self-harm, and a pervasive sense of hopelessness. One caregiver said plainly: “I believe that if I didn’t get him help, he would have killed himself.”
The Surgical Evidence Is More Complicated
When it comes to gender-affirming surgery, the data is harder to interpret. A large database study published in Cureus in 2023 found that individuals who had undergone gender-affirming surgery had significantly higher rates of suicide attempts compared to control groups, including a 12-fold higher risk compared to the general population and roughly a 5-fold higher risk compared to people who had undergone other non-cosmetic surgeries. These numbers sound alarming, but they require careful context.
This type of study compares transgender people who had surgery to non-transgender people. It does not compare transgender people before and after surgery, which means it cannot tell you whether surgery made things better or worse for those individuals. Transgender people as a population face higher baseline rates of suicidality driven by discrimination, stigma, and minority stress. A comparison to the general population captures that disparity, not necessarily the effect of the surgery itself. The study also could not account for the severity of gender dysphoria, prior mental health history, or social support, all of which heavily influence outcomes.
Most studies that evaluate surgery also involve patients who are simultaneously receiving hormones, making it difficult to isolate the effect of surgical procedures alone.
Evidence Quality and Limitations
While the overall direction of the evidence points toward benefit, the quality of that evidence has real limitations. A commentary in The Lancet noted that systematic reviews in this area frequently rely on studies with small sample sizes, short follow-up periods (sometimes only 3 to 12 months), no control groups, and moderate to serious risk of bias. One key systematic review cited to support gender-affirming care included only three uncontrolled studies, and its own authors described the results as “low quality evidence” unable to offer conclusive findings.
Another systematic review of 20 studies found that 85% had a moderate, high, or serious risk of bias. Confounding factors, where people receiving care also had access to better social support, therapy, or other resources, limit the confidence of conclusions. Critically, no existing systematic review has been able to draw firm conclusions about death by suicide as an outcome, largely because completed suicide is statistically rare even in high-risk populations, making it extremely difficult to study directly.
None of this means the findings are wrong. It means the evidence base, while consistent in direction, is not yet as rigorous as researchers and clinicians would like it to be. Most of the available studies are observational, not randomized controlled trials (which would be ethically difficult to conduct in this context).
Family Support Plays a Major Role
Medical care does not operate in a vacuum. Family acceptance is one of the strongest predictors of whether a transgender young person will struggle with suicidal thoughts. Data from The Trevor Project shows that transgender and nonbinary youth who came out before age 13 and had high family support reported a past-year suicide consideration rate of 44%, compared to 67% among those with low or moderate support. The gap in actual suicide attempts was similarly large: 17% versus 30%.
The WPATH Standards of Care note that rejection by family, peers, and institutions is strongly linked to depression, suicidal ideation, and suicide attempts among transgender people. Discrimination itself is a direct predictor of suicidal ideation. This means that even with access to medical interventions, a transgender person living in an unsupportive environment faces elevated risk. Conversely, strong social support can be protective even when medical care is delayed.
The most effective approach, based on available evidence, appears to involve both appropriate medical care and a supportive social environment. Gender-affirming care addresses the internal distress of gender dysphoria, while family and community acceptance address the external stressors that drive much of the mental health burden transgender people carry.